Showing results (1691-1700 of 2,391) with videos related to
Sort By:
Pageof 240
Digestive Diseases (Basel, Switzerland)|November 8, 2014
Decreased blood flow after sorafenib administration is an imaging biomarker to predict overall survival in patients with advanced hepatocellular carcinomaTadaaki Arizumi, Kazuomi Ueshima, Hirokazu Chishina, et al.Digestive Diseases (Basel, Switzerland)|November 8, 2014
Identification of epigenetically inactivated genes in human hepatocellular carcinoma by integrative analyses of methylation profiling and pharmacological unmaskingNaoshi Nishida, Hirokazu Chishina, Tadaaki Arizumi, et al.Digestive Diseases (Basel, Switzerland)|November 8, 2014
Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristicsHaeryoung Kim, Young Nyun ParkDigestive Diseases (Basel, Switzerland)|March 17, 2016
'Treat to Target' - Lessons LearntZsuzsanna Kurti, Zsuzsanna Vegh, Petra Anna Golovics, et al.Digestive Diseases (Basel, Switzerland)|March 17, 2016
Calprotectin or Lactoferrin: Do They HelpEmily K WrightDigestive Diseases (Basel, Switzerland)|March 17, 2016
Psychological Stress and Depression: Risk Factors for IBD?Charles N BernsteinDigestive Diseases (Basel, Switzerland)|March 17, 2016
Anti-TNFs: Originators and BiosimilarsGerassimos J MantzarisDigestive Diseases (Basel, Switzerland)|October 22, 2015
Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular CarcinomaNaoshi Nishida, Masayuki Kitano, Toshiharu Sakurai, et al.Digestive Diseases (Basel, Switzerland)|October 22, 2015
Usefulness of Cytokeratin-18M65 in Diagnosing Non-Alcoholic Steatohepatitis in Japanese PopulationYutaka Hasegawa, Soo Ryang Kim, Takashi Hatae, et al.Digestive Diseases (Basel, Switzerland)|October 22, 2015
Characteristics of Hypovascular versus Hypervascular Well-Differentiated Hepatocellular Carcinoma Smaller Than 2 cm - Focus on Tumor Size, Markers and Imaging DetectabilityKayo Sugimoto, Soo Ryang Kim, Susumu Imoto, et al.Pageof 240